The transcriptions provided on this website are generated using artificial intelligence (AI) technology and may contain significant errors, including instances where the AI system can incorrectly add or invent content that was never actually spoken in the original audio. These errors may include fabricated medical terminology, non-existent treatments, incorrect demographic information, or other invented content that was not present in the original recording. These transcriptions of radio shows discussing integrative cancer therapies are provided solely as part of Yes to Life’s educational resources to help cancer patients and their families learn about additional therapies and treatments that may be available to support them before, during, and after medical treatment. Neither these transcriptions nor the original audio recordings constitute medical advice or endorsement of any particular treatment, practitioner, or clinic. By accessing these transcriptions, you acknowledge that Yes to Life does not guarantee their accuracy, completeness, or reliability, and expressly disclaims liability for any errors, omissions, or misinterpretations. All medical decisions should be made solely in consultation with qualified healthcare professionals. These transcriptions are protected by copyright law and are the property of Yes to Life. If you identify errors or inaccuracies, please contact us immediately at office@yestolife.org.uk for correction.

Robin Daly
Hi and welcome to the Yes To Life show . My name’s Robin Daly and I’m the regular host to the show as well as the founder of Yes To Life, the UK’s integrative cancer care charity that supports people with cancer in finding out about the many options available to them to help them recover their health and well-being through integrative medicine. Mistletoe is one of the most established and best known adjunctive therapies with a long track record of successfully supporting people at every stage of cancer and cancer treatment. Sarah Monz works at Iscador AG, the company that’s been manufacturing mistletoe preparations for more than a century. Hi Sarah, great to have you on the show.

Sarah Monz
Hi Robin, thanks for the invitation.

Robin Daly
So mistletoe as a therapy has highly unusual beginnings, but it’s gone on from there to be I’ve been told, and maybe you can confirm this if it’s actually true, the most commonly used cancer therapy on the planet. Is that actually verified?

Sarah Monz
That’s right. Just with the addition that it’s not the most commonly used cancer therapy, but the most common complementary or phyto-based medicine that is used in the treatment of cancer. That’s right.

Robin Daly
support for mistletoe varies enormously from one country to another. It’s notably great in Germany, notably pathetic in the UK and the US, I think might be even worse. Do you think things are improving here for us in the UK? What do you think are the limiting factors?

Sarah Monz
Oh, yes, indeed. So the limiting factors to mistletoe being more widely known have been historical. So basically, due to the fact that the therapy was invented or devised in Switzerland, and then just spread throughout the German speaking medical community, it came out to be just fine for almost 100 years, maybe something like the best secret of doctors in the area. And even the companies producing mistletoe based remedies were not so keen to expand because they were making fairly good business. They couldn’t complain all the way up to the turn of the millennium, so to speak. When there was indeed a crackdown on complementary remedies and integrative approaches in these countries. So these interventions, modalities and remedies were kicked off from reimbursement. And so the prescriptions and sales went down. And then people started thinking, well, why not make some bigger international studies to really prove that we have something because they hadn’t really needed anything like that in the past. It was just something that was there. Everybody was using it. Everybody liked the outcomes. Everybody was satisfied. It was never questioned. And then with that political decision to say, well, it’s nice that you like your remedy, but you have no science to back it up. Something had to change. And of course, there was a bit painful in the beginning, but I think the direction was right. Of course, you do need scientific studies and prove that you’re doing the right thing. You need the data for patient safety. That’s all really necessary. And that’s actually a good thing. And that’s sort of been the basis of mistletoe becoming more widely known in other countries. It is. And interest is growing. And I think, yes. So in my opinion, the UK is not doing so badly at all. Okay.

Robin Daly
It’s a rare thing to say about integral to medicine in the UK, it seems to be right on the back of a cube. But anyway, all right, well, that’s great. And you’re right, of course, the direction of travel to have more science, it’s got to be good. You know, typically, most things that arrive on the scene that are said to help with cancer start off as being like, yeah, it’s great for everybody, wacky dad is completely safe. But you know, if the science is followed, you find a few years later, that actually is great for a subset of people, like the other people who might do nothing for it all. And there might be situations in which it is actually risky. So those are the things we need to know for sure. So so yeah, so it’s a good direction of travel. Okay, so back to the origins of mistletoe as a cancer therapy, I believe it’s got a long history actually of several hundreds of years as a medicine, a century or so ago, it took a turn that it hasn’t looked back from. Can you tell us the story?

Sarah Monz
So the story was about a young lady, a Dutch lady was actually born in what is today Indonesia and wanting to not really exactly just yet pursue a career in the medical field because that was unthinkable at that time for our ladies but she went to Europe to become what we today would call a physiotherapist. That was Ita Vikman and she was really keen on helping people who were eating and she was also very spiritually interested and she got in touch with Udo Steiner or whose talks she visited and she did in fact also had had a private contact with him and his wife and eventually his wife told her why don’t you go to Switzerland and study medicine because that was the only place in Europe in those days that was 150 years ago where ladies were permitted to become medical doctors. So she did that. I believe she was way past her 20s already but she pulled it through. She became a gynecologist and she started treating patients and she started encountering cancer patients and she was really desperate because back then there was nothing anyone could do to help these people. They would just you know waste away and nobody really understood the nature of the disease. People were in a lot of pain and they basically died miserably. So she was in contact with all kinds of colleagues and apparently that’s something she later related. Some French pharmacologists told her about the traditional use of mistletoe in their country which was used as a remedy to strengthen weak people and she thought oh that’s interesting and then she also talked about that with Steiner and he had done some independent research. He was also really fascinated with mistletoe and so they both thought that’s a good idea and he gave her some input that she then proceeded to apply together with a pharmacist in Zurich who produced a remedy for her that was an injectable solution based on mistletoe. It was an alcoholic solution which means it must really have her to inject that stuff. but she started using it and she started to see results. And from that point on, she really devoted herself to further develop and improve this path. And in the years that came later, she founded her own hospital, which is right next door to my office where I am here right now in Switzerland. And she invited Rudolf Steiner to work together and devise something that in the idea, basically already was the concept of integrative medicine, meaning the employment of all the scientific means available at that time, plus many, many complementary interventions based on traditional knowledge, physiotherapy, also things like meditation and movement therapy to make patients better and help them to get over their oftentimes terrible therapies that they had to endure. Yeah, and so to speak, mistletoe was at the beginning of all of that, which is quite amazing.

Robin Daly
So this is anthroposophical medicine you’re describing, which, yeah, it is a remarkable thing. It’s, you’re right, the attention to, you know, the caring environment, if you like, of anthroposophical medicine is remarkable. And also, as you point out, it was a very long time ago, it was way ahead of the herd in terms of that kind of thing. Very interesting. So this, yeah, this is all part of it being developed as part of anthroposophical medicine now. So it sounds like the mistletoe was as much a sort of concept idea as anything in terms of this could help rather than being based on clinical use. Is that correct?

Sarah Monz
And that’s amazing. Yeah, because it was made one out of desperation. We have to try something. Let’s let’s do this. And it was like a full score.

Robin Daly
Yeah, I mean the chances of hitting on something that works and doesn’t just work but actually it works really quite well and it is well it’s minute you think so but you know a large part of this I understand or an important part of it was Steiner’s own sort of insights into the nature of mistletoe. Do you want to talk about that a bit?

Sarah Monz
Yeah, and that’s also a very interesting story, because the person Udo Steiner might be somewhat controversial these days, but in fact, there are many, many sources that proves that already at the beginning of the 20th century, around 1904, 1906, Steiner was studying nature. I mean, that was a really common thing in these days. It was a time, also, if you think of the arts or literature, where people turn to nature and try to understand nature, get a more intimate connection with nature. And, apparently there, Steiner already noticed that there was something peculiar about mistletoe, the way it’s a plant that grows on other plants. It never wants to touch the ground. It doesn’t develop roots, but it hangs suspended somewhere between heaven and earth, with its foot, basically. It doesn’t even have a wood, but it just digs into the twigs and branches of other trees to get nourished from what they have inside. So that’s all very, very strange. And in the beginning, also considering that its parts and its berries are poisonous, he had a very unfavorable image of mistletoe. He is documented to say things like, oh, this is just something straight out of hell. It’s not even from this earth. It’s just totally evil. And then he apparently did some more research into that, and also noticed how it is a very strange plant, but it must be judged, possibly, by human standards, because it’s a plant, after all. And it’s embedded into this web of nature. It’s a food source for animals, and the way it looms in winter, and also has its berries in winter, and is so totally backwards, also has its merits. On the other hand, it’s a very peculiar characteristic, because that’s also something he noted. Mistletoe does everything different. It’s totally backwards by itself. Interesting. And so, then he also, he was in touch with other philosophers, and also a natural therapist of his time, like the proponents of specurics and tomoeopathy. And from there, he developed this certain perspective of also looking at plants, sort of from a different point of view, meaning, what could they be used for? And then, probably, an etheric man told him about her idea to use Mistletoe to strengthen people. All this came back to him, and he said, oh, yeah, let’s pursue that. And let’s try what we can find.

Robin Daly
Very interesting, quite a story. Anyway, OK, so the company that you work with, of course, is very implicated in the story as well. Do you want to just quickly tell us how it fits in?

Sarah Monz
Yes. The company is actually very young, but the remedy that we produced is actually the remedy that was maybe, so to speak, the follow-up product of that first injectable Ita Wichmann and Rudolf Hauser and Zurich came up with. As I’d said, there were numerous instances where they felt like they had to rework the formula to improve outcomes and make it just easier for people to use it. And so after the first remedy, which was called ISCAR, they registered a remedy called ISCADOR. And that was the one that afterwards really made it big, so to speak. And even had its own hospital where it was the the main therapy. main remedy, together with the modalities of the anthroposodic medicine. And it was then also distributed by Venida, that we all know, the company we all know. But then with these economic changes around the turn of the millennium, Venida was not ready anymore to keep going the same way. Because there were all these kinds of trouble, all these changes.

Sarah Monz
And then so the idea was either to substantially cut back on the range of products available, because there’s products from tithe, different host trees of mistletoe, in different strengths, dosages available, and then also together with homeopathic additions of certain metal salts to enhance the effect, which also goes back to an ideal wood of Steiner. And so the idea was to really cut back the product range, and then the Society for Cancer Research, which is an entity that was founded by Ita Lichtman herself back in the days. And they’re sort of like the guardians of mistletoe and the science behind mistletoe. They were saying, no, we’re not tolerating this, so we’re coming up with all the money to bail out Veneda and do this on our own, basically, just to ensure that all the mistletoe products remain available for patients. And that’s because, of course, just like a society or a club couldn’t register a remedy, or they keep all the remedy, they founded this company called Iscador.

Robin Daly
And your role in the company is?

Sarah Monz
I am with the executive board. My background is a medical doctor and so I’m basically heading everything that has to do with medical questions and medical communication.

Robin Daly
And what drew you to this job in particular?

Sarah Monz
I was lucky. I’m a pain therapist and I studied a number of complementary modalities and was able to practice that in my practice in Switzerland and I was also lucky to learn about mistletoe therapy and treat patients with it. For some strange reason, one day I got a call. The phone rang and I was someone asking if I would be interested to hear about a job opportunity. I was doing medical communications for a naturopathic company. I said well this is really odd. It’s strange so let me hear what it’s about. Okay. And now it’s the two of us talking on zoom.

Robin Daly
we’ve got a lot of stuff I want to talk about today, but I want to make sure that we have time to talk about the kind of practicality so patients have more of a feel of what’s involved and same with practitioners. But maybe you could just briefly summarize where we got to with the science, what things are kind of established and what things are looking like that will be established fairly soon.

Sarah Monz
So at the moment we’re really looking back at almost 100 years of scientific research and that’s a great situation. Of course in the 50s and 60s data quality was different but outcomes were documented that’s important and even the most recent studies are numerous enough including older studies with really good data quality to have meta-analyses available for us today. So regarding Mistletoe, Renardini, we can say that it’s really been established that they’re able to significantly improve patients’ quality of life and that is something that may sound a bit abstract to us but when it comes down to what it means or different aspects of quality of life it comes down to the general state of being, the way health can be conserved even in the course of malignant disease, even over the course of chemo treatments, radiation and yes that’s actually been shown for the majority of of Mistletoe preparations that it’s possible to achieve that. So that’s major. And of course this has a consequence if people remain in better shape, if they’re able to eat and sleep right, if they’re able even to work they will live longer even though they have this type of disease, even though they are undergoing all these excruciating therapies. So there are meta-analyses regarding overall survival which is increased in the patient in addition to their standard ecological therapy we’re listening to Mistletoe treatment.

Robin Daly
amazing that’s fantastic and yeah do you see uh research sort of in the pipeline which is going to establish any other important points i mean the one of quality of life is amazing because of course anybody who’s experienced going through chemo and the side effects it can bring will know the quality of life is everything you know it’s like you can get to that is life worth having stayed without support so um yeah so that’s fantastic but yeah is there anything in the coming up as well which you’re excited about

Sarah Monz
So, where we need to stay on top is the exponential growth in the field of oncological remedies. I know that this is a challenge for all doctors working in this field as it were, but now we need to remain sure that all these new therapeutic options remain compatible with Mistletoe, or Mistletoe remains compatible with these new possibilities. Yeah, very important. That’s a major thing and the amazing development, in my opinion, is we’re seeing a paradigm shift in oncology altogether, back from one size fits all chemo to an individualized treatment that pays much more attention to the patient’s immune system that also works with the patient’s immune system and the ways it is so intricately steered, for instance, by the microbiome. All of this that’s been sort of discussed in complementary medicine for the past three decades and has always been laughed about. It’s now out on the table and everybody agrees it’s the next big thing. This is where we need to be going in order to really, really help people. This is something where Mistletoe actually blends right in. There will be studies soon. There will be first results on the combination of Mistletoe with immune checkpoint inhibitors this fall. I know there are plans for a major study to put Mistletoe into the perspective, into the big frame of what is happening in the immune system in the case of cancer disease and the course of treatment with the new remedies. For me, it’s really exciting. Because the one question that has always remained open mainly due to technical and analytical difficulties was that it has not been possible to explain 100% all the working mechanisms that take place if one uses Mistletoe. Of course, there might be surprises coming up, but we want to know the main path, how Mistletoe interacts with the immune system. I think we’re about to learn a lot about that in the next coming years.

Robin Daly
I think so, well of course the capabilities for analysis of what’s going on are so much enhanced now, aren’t they? We can look quite easily at immense detail now. So yeah, but it’s very interesting, the point you make, you’ve gone basically from the old paradigm of killing cancer cells and a lot of other stuff while you’re at it, unfortunately, to aiming to support the immune system, which of course is at least you’re on the same page with mistletoe. I mean, you know, the chemotherapy destroys the immune system while theoretically killing the cancer cells, whereas the immunotherapy is at least working sort of in parallel. So it does change the ballgame significantly. Very interesting. Thanks for that. Okay, so let’s talk a little bit now about who can be treated with mistletoe. I think, you know, from what I’ve heard, one of the reasons that it’s so popular is that there’s, you know, almost nobody with cancer that can’t benefit from mistletoe, am I right?

Sarah Monz
Yes, technically yes. On the other hand, being here the representative of a company, if we look at the registration, the mistletoe is registered for the treatment of solid tumors as well as cancerous lesions. That is where we navigate. We know that there are people out there who successfully treat patients with things like lymphoma, other types of cancer behaving actually really differently. From my point of view, I must say, I don’t have the studies to back that up. If someone has good experiences, and I know quite a few doctors who say, well, and having so many lymphoma patients on mistletoe, they’re all doing great, I’m not going to change that. Then I say, well, no, you shouldn’t change anything. But yeah, so that’s my brain.

Robin Daly
So clinically it’s being used with like blood cancers and lymphomas and actually there’s no reason to suppose it wouldn’t work, is there? Maybe.

Sarah Monz
because these types of cancer that come from blood cells, they tend to interact differently within the immune system. So I would say it should be done really cautiously. And maybe that was one of the reasons that back in the 19s or early 2000 years, people were not so keen on starting bigger studies because they weren’t very sure about the outcomes.

Robin Daly
Okay, well fair enough. But anyway, you’re hoping the evidence for that will come in time. Just out of interest, brain cancers can be difficult to treat because of the blood-brain barrier. And how does mistletoe get on there?

Sarah Monz
Yeah, also considering that a mistletoe doesn’t have to cross the blood brain barrier, but the immune cells would. So, indeed, we do recommend from our product Escador, that’s the mistletoe from Pine, that can be used in the treatment of brain cancer. I cryoplastoma, that was in fact, one of my first mistletoe patients. Oh, enough. Whether it was a cryoplastoma, I was able to treat and it was just a mind-blowing experience to see patients who did not go with that path, that were not eligible or didn’t want mistletoe and this one person what the mistletoe therapy did for him, how well he kept in the way that in the beginning, a very intimidated and depressed person was able to, with this prognosis of cryoplastoma, really open up and really reflect on his life and make wish lists and really say, well, okay, now, if that means I have six more months, this is what I’m going to do. And it was just a breathtaking experience to witness that totally unusual.

Robin Daly
Okay, so you keep mentioning, first of all, the range of products that the Iskadil produce, and you just mentioned one particular one, which is mistletoe from pine trees, yeah. So you’ve got, I think, was it five different kinds? Yeah, okay. Why? Give us a little bit of background on why it’s different.

Sarah Monz
So that is really actually an amazing story that I was able to research because when I started, everybody told me we don’t know. So what we do have is we have two conifers. We have the fur and the pine, and we have two deciduous trees, apple and oak, as the main host trees for our mistletoe products. And then there’s like a fifth addition to the family. There’s elm, but the elm products are reserved more or less exclusively for the treatment of lung cancer. And that has to do with a traditional European doctrine of signatures. And that for me was the key to look at the other trees through the looking glass of the doctrine of signatures. And what you can find there is it’s really amazing. We will publish that later this year that basically it goes back to the doctrine of signatures. It goes back to looking at the characteristics of a plant. or in that case a tree, and then extrapolating these characteristics to a medical problem or to a role of treatments of a medical problem.

Robin Daly
just give me an example so that we can get our teeth into this.

Sarah Monz
So the one prominent example is Rudolf Steiner’s statement about if you want a remedy to treat all kinds of cancerous diseases of the lower abdomen, and by that he meant the reproductive organs. You should use mistletoe from an apple tree and put that together with the silver potentized metal salts. This is not the one-on-one quote, but this is essentially what he said. And so people say, okay, okay, let’s do that. And nobody asked why, exactly. Just do it. And so if you look at the apple tree, and it’s a really small tree. It’s really close to the earth. It has this earthly quality. It also has this nourishing quality. It produces apples that can nourish their sweets. They’re really juicy. They nourish animals and people alike. And otherwise, what this tree will do is it will produce flowers so it doesn’t produce anything that’s prickly or poisonous. It makes things that are pleasant, that will elicit positive responses that is nourishing. In a way, it’s a caring tree because it cares for so many other beings just by being there.

Sarah Monz
Um, and, and so this is something that you could extrapolate to, um, the reproductive system. It’s, you know, where the new lives comes into being, it’s, um, the element of water that is present, um, that is in, in, in mythology notes, the source of all life. Generally, we know from science, in fact, science and mythology are sometimes not so far apart. Um, and so this, um, also this, uh, relation to water, we find that in the apple tree. And so this is basically what the doctrine of signature does. It, it looks at one thing and tries to find patterns or similarities in the human being in them, in the microcosm, so to speak.

Robin Daly
OK, so this seems like the art side of science to me. It’s like, you know, this is right. OK, well, interesting. OK.

Sarah Monz
It’s by the way, the funny thing, or maybe the not funny, the remarkable thing is that this is how medicine was devised, you know, in the first place, yeah, in the first place, many, many, many thousands of years ago, people didn’t have randomized control studies, no, it had to look at what was out there and somehow make sense of it.

Robin Daly
So in many ways you can all the remedies that were found being intuitive medicine and of course you know intuition these days is gaining a lot more credibility as being one of the most important tools for somebody who’s sick with cancer in order to find their way out of the maze and people are citing it as one of the key factors that enabled them to get themselves well. So intuition is not to be sniffed at it’s obviously a great thing but it doesn’t stop scientists saying come on okay that’s all very well but we want the hard data. So interesting. So look I want to talk about the ways in which mistletoe is administered how for many years there was just the one way I think which is the subcutaneous injections that you described but recently due to pioneering work by people such as Dr Morris Orange there are now more ways of doing this. Do you want to talk about the different ways that it’s administered now?

Sarah Monz
But basically, I think in about 95% to 98%, it’s still administered subcutaneously. Then of course, it’s always been a possibility to also take mistletoe extracts orally. However, there haven’t been any clinical studies on that. But what we’re hearing is case reports after many decades where it was just something that was being used and the manufacturing companies really didn’t care all that much. We’re getting feedback that, yes indeed, things are happening when people take mistletoe orally. So this is something that we’re now going to look at. One of the reasons it wasn’t really taken seriously was the fact that proteins that are contained in the mistletoe extract were sought to degrade in the stomach. Right. But we do know this is about lectins and lectins are what make things like nightshades troublesome. So they’re really highly concerned even if they go through the stomach, if they’re passed through it. So it’s actually no surprise that there are clinical results with people and also animals being treated with oral mistletoe extract.

Robin Daly
it will be interesting to find out. Yeah, it’s much more controversial, the oral efforts. You know, I hear everything from like, no, it’s a waste of time to other people saying, no, no, no, that’s all we do. So, you know, it’s one of those things that, yeah, we need some hard facts, obviously. But the subcutaneous, that’s something that, as you say, nearly everyone’s doing involves just small injections just below the surface of the skin. People do it themselves, at home, generally. And it’s not a big deal to do. So, you know, if anybody’s interested, it’s not too horrendous to negotiate at all. I was referring also there to some of the experiments that were being done with intratumoral use of mistletoe. Now, I don’t know how common that is now, whether it’s taken off and is found to be useful, or what can maybe you can tell us.

Sarah Monz
Yeah, that is definitely something that is being done. However, I think doctors doing that should really take care and a long time to study from experienced colleagues, because endotumoral injections are really something to take lightly. But then on the other hand, yes, we do have these two components, the mistletoe, nectans, and viscotoxins, the toxic proteins in mistletoe, that are directly cytotoxic, especially on cancer cells that have less possibilities to repair themselves at being damaged, which is of course the principle behind chemotherapy. And then on the other hand, our immune system does react quite strongly to them. So that’s the point behind the subcutaneous application. But of course, you can just use the full force of mistletoe against the tumor. And if possible, if it’s manageable, use it for intertumoral injections. And that is done at the institution right here next door and integrative oncology.

Robin Daly
Yeah. So, given that I’m sure there isn’t anything that would, you know, add up to being full scale evidence, there must be some accumulation of data there, and could you want to give an idea of what the results are?

Sarah Monz
So these are mainly case reports and I’m in touch with the colleagues. Well, of course, really busy, but we tell them that it’s really necessary to pull together like a collection of cases to really evaluate what the benefit is. And they do have cases of full remission, but of course, it’s not a monotherapy. Yeah. It always goes together with the usual treatments, but then, yes, there are these accounts of too much shrinking and then, yeah, just going. Just going, right. Yeah, if they haven’t metastasized or anything before, yeah.

Robin Daly
Yeah, I’m stood well very interesting and that’s one for the future isn’t that obviously that’s With some level of success you’re bound to pursue it and we’ll find out what it really can do Okay. Well, look, we just got a few minutes left. Do you want to just do a Whistle stop summary of the benefits that somebody with cancer might get from mistletoe at every stage Going through from when they dug those to long after being treated

Sarah Monz
Okay, let’s try. So we do recommend that mistletoe started as soon as the diagnosis is known. Of course, because you have the possibility to stabilize the immune system for whatever will come afterwards. So what mistletoe will do is apparently improves the signaling the way the immune system, the immune cells talk to each other, the way they are able to interact efficiently and meaningfully against the tumor and basically also to conserve overall health. And then on the other on the hand, of what especially the Iscado products will do. Overall activity improvement of the immune system, which also means support of body temperature, support of a mood and sleep and all the vegetative circles that basically govern our health. What would we consider normal for our bodies? Things like appetite, things like I said before, mood, sleep, the ability to put on weight, not to waste away. All these things that are really regulated from within the body tend to suffer during the cause of cancer and during chemo. So mistletoe is something that will help you pull all of this together and pull through basically on the other side.

Robin Daly
what about beyond treatment?

Sarah Monz
Yes, beyond conventional therapy, as this may be finished eventually, we do have this challenge that there are many cancer survivors who luckily have beat the disease, but end up with fatigue being a major part that takes away quality of life, even after cancer has been overcome. So, in fact, there’s also a meta-analysis that came out last year that we do see much less fatigue in mistletoe patients. And that also, even if a patient goes through chemo and convention treatment without mistletoe, ends up with a fatigue after treatment, it is possible to treat this fatigue with mistletoe so people will be able to reclaim their lives.

Robin Daly
that’s a big one and are you able to say anything about recurrences and the prevention of them?

Sarah Monz
So, that’s the other big thing that mistletoe can do after conventional treatment is finished. It does have a prophylactic property to guard and protect against a renapsance. There’s been a study done with sarcoma patients quite a while ago where this was shown that sarcoma is a type of cancer that tends to relapse a lot, that in fact over the course of ten years after the study had been finished, the study population that had the patients that had received eschatol remained completely relapse free while everybody else in the other group were not received because they had had their relapse. Black and white, eh? It was a very small, it was a pilot study. People were really anxious to repeat this study on a larger scale and it took a long, long time including to make it through COVID, the corona years and now it seems like this gets its green light and we’re starting the study.

Robin Daly
And that is so major though, is now I mean, you know, say you forget everything else that Mistletoe does and you say, okay, it prevents relapse. I mean, how many patients relapse with sarcoma, this massive number. And when they do relapse, it’s usually, oh, you’re stage three, stage four. It’s a death sentence. So it’s not a complete life destroyer. So you know, that is such a major thing if we can actually prevent relapse. So, yeah, something for people to sit up and take note of. All right. Well, look, we’re out of time. Is there any website you’d like to point our listeners towards to find out more?

Sarah Monz
There is a very useful website to inform themselves as a patient or as a family member, even as a medical doctor that’s managed by a mistletoe administering doctors in Germany and Switzerland. It’s called mistletoe-therapy.org. It’s basically the one-stop shop for all things Misoto.

Robin Daly
very helpful. Okay well look very many thanks for coming on the show today and sharing so much information about therapy. An enormous number of people are interested in this. It always has been as long as I’ve been doing this job so I’m confident that you know what you’ve said today is going to be very helpful to many people so thanks very much Sarah.

Sarah Monz
Thank you very much Robin. Have a great day. Bye bye.

Robin Daly
If you’re someone who has or has had cancer, if you’re not already using Mistletoe, then that interview should have provided you with sufficient reasons to look into the possibility. A great new resource for those who are interested has been published recently. It’s called Mistletoe and the Emerging Future of Integrative Medicine. It’s by Dr. Nature Winters and Dr. Stephen Johnson. You can read more about that at themistletoebook.com. And you can also find out more about Iskador at Iskador.com. Thanks for listening to the show today. I’d love you to join me again next week, when I’ll be introducing another expert guest from the world of integrative medicine for cancer in the next Yes To Life show.